The selective depletion of CD4+ or CD8+ T cells led to a marked elevation in tumor volume compared with normal IgG-treated mice (P<0.01; Figure 7a), suggesting that RdB/IL23/p35 induces both CD4+ and CD8+ T cells-mediated antitumor immune response. This evidence concerns the gene CD4 and neoplasm.